Evaluating Biopharma
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.
Episodes
24 episodes
Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance
In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data provenance—why they matter and how the industry can achieve them. With 30 yea...
•
Season 1
•
Episode 23
•
16:49
Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Chris Major, founder and partner of BioProcess360 Partners, discuss the best ways to start a company to address technology gaps, why it is beneficial to collaborate with compe...
•
Season 1
•
Episode 22
•
35:01
Episode: 21 - How AI is Changing the Antibody R&D Game
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Tony Arulanandam, SVP and head of R&D at Cytovia Therapeutics, discuss how AI is impacting the antibody R&D field, how companies are using AI to generate better sequen...
•
Season 1
•
Episode 21
•
31:35
Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix
In this month’s special episode of Evaluating Biopharma, host Ben Locwin interviews Mara Strandlund, chief people officer at National Resilience, and Niamh Alix, chief human resources officer at Prime Medicine, about the upcoming Talent in Biop...
•
Season 1
•
Episode 20
•
19:38
Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and gene therapies and what sets them apart from other therapeutics in terms of...
•
Season 1
•
Episode 19
•
17:20
Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts
In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about bispecific antibodies. Dr. Schmidt goes into detail about current trends (from a CRO’s perspective) regarding the discovery and de...
•
Season 1
•
Episode 18
•
23:56
Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin
In this episode of Evaluating Biopharma, host Ben Locwin and Jamie Martin, PMP, senior consultant at Black Diamond Networks, discuss the tips and tricks of successful program management. Martin shares his mental checklist of must-haves to ensur...
•
Season 1
•
Episode 17
•
22:56
Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma
In this episode of Evaluating Biopharma, host Ben Locwin speaks with Brian Tham, principal consultant at Peregrine Bio, LLC, on how various projects are run in the pharmaceutical industry, how to improve the outcome and processes of projects, a...
•
Season 1
•
Episode 16
•
21:21
Episode: 15 - Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa
In this month’s episode of Evaluating Biopharma, host Ben Locwin speaks with Nesredin Mussa, PhD, president of Dynamica Biologics, about navigating the challenges of securing successful CDMO-sponsor relationships for a rare disease manufacturin...
•
Season 1
•
Episode 15
•
19:42
Episode: 14 - Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt
rocess intensification can be an overwhelming experience. In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about strategies and approaches that can help you understand and figure out ho...
•
Season 1
•
Episode 14
•
16:08
Episode: 13 - Identifying Impurities In Gene Therapy With Santoshkumar Khatwani
In this episode of Evaluating Biopharma, host Ben Locwin speaks with Santoshkumar Khatwani, Director – Analytical Development, Late-Stage CMC Analytical Team Lead at Sangamo Therapeutics, about impurities in gene therapy processes and the ways ...
•
Season 1
•
Episode 13
•
19:38
Episode: 12 - The Risks and Rewards of Speed-to-IND Strategies With Susan Jones
What are some strategies that companies can use to get to IND filing quickly? In this brand new conversation, Evaluating Biopharma podcast host Ben Locwin discusses the risks and rewards of speed-to-IND strategies with Susan Jones, Chief Techno...
•
Season 1
•
Episode 12
•
19:32
Episode: 11 - Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy
In this episode of Evaluating Biopharma, host Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Jonathan Tsang, Senior Director, Manufacturing Sciences & Technology at Kite Pharma, who shares his experie...
•
Season 1
•
Episode 11
•
21:49
Episode: 10 - Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business
In this episode of Evaluating Biopharma, Mike Kelly, Senior Vice President at Atsena Therapeutics, shares his experiences and provides his advice on how your company can make proper CMC investments to reduce risk and maximize ROI, including: th...
•
Season 1
•
Episode 10
•
22:43
Episode: 9 - Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy
In this episode of Evaluating Biopharma, Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Susan D'Costa, Chief Technology Officer at Alcyone Therapeutics, who shares her experiences and provides advice on h...
•
Season 1
•
Episode 9
•
24:32
Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy
Joseph Shultz, VP and technical head of biologics and vaccines at Resilience, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss the financial considerations biopharma companie...
•
Season 1
•
Episode 8
•
20:08
Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy
Marty Giedlin, vice president and head of technology operations at Senti Bio, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, to share his experiences and provide advice on how allogeneic cell th...
•
Season 1
•
Episode 7
•
27:22
Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing
Arthi Narayanan, innovation team leader of pharma technical operations at Genentech, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss how process analytical technology, artif...
•
Season 1
•
Episode 6
•
19:15
Episode: 05 - Navigating Scale-Up Challenges in Protein Production
Parrish Galliher, an independent bioprocess consultant, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the context-dependent issues that arise when scaling-up protein production. Gallaher ...
•
Season 1
•
Episode 5
•
20:45
Episode 4: Anticipating Disruptions: Identifying and Planning for Shortages
In the biopharma space, nearly every moving part is contingent upon a functioning supply chain. In this month’s episode, moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, speaks with Rich Musa, director and he...
•
Season 1
•
Episode 4
•
19:42
Episode: 3 - Cell and Gene Therapy: Managing the ‘Build or Buy’ Decision
Dave Backer, founder of DB Biologics and former chief commercial officer at Oxford Biomedica, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the complex business and technological decision...
•
Season 1
•
Episode 3
•
22:36
Episode: 2 - Operational Efficiencies: Lower Operational Costs by Reducing Clinical GMP Sampling
In this episode, Josefine Persson, Genentech associate director, and Ben Locwin, Black Diamond Networks vice president of project solutions, discuss how the cost of oversampling from clinical GMP runs versus development sources equates to high ...
•
Season 1
•
Episode 2
•
25:12
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection
In the inaugural episode of Evaluating Biopharma podcast, CPI’s Simon Hawdon speaks with Moderator John Bonham-Carter about the benefits of converting from batch to continuous processing and the critical decisions involved in making a ...
•
Season 1
•
Episode 1
•
21:53
Episode 000: Introducing the Evaluating Biopharma Podcast
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and...
•
Season 1
•
Episode 0
•
2:07
